Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck drug safely cuts prostate cancer risk, study finds
Yahoo/AP
Wednesday, August 14, 2013 - 9:21pm
tags:
Merck, prostate cancer, Proscar
Forest Labs, Almirall delay NDA filing for Aclidinium/formoterol combination
Yahoo/Fly on the Wall
Wednesday, August 14, 2013 - 4:28pm
tags:
Forest Labs, Almirall, COPD, aclidinium bromide, formoterol fumarate
Could The FDA Have Prevented Bacterial Infections Traced To A Compounder?
Pharmalot
Wednesday, August 14, 2013 - 4:27pm
tags:
FDA, compounding pharmacies, Specialty Compounding
Theravance reintroduces Vibativ to the U.S. market
The Fly on the Wall
Wednesday, August 14, 2013 - 11:21am
tags:
Vibativ, Theravance, hospital-acquired bacterial pneumonia
BioDelivery Sciences Posts Loss Y/Y
Yahoo/Zacks
Wednesday, August 14, 2013 - 11:19am
tags:
BioDelivery Sciences, earnings
AVEO Pharma Cuts Q2 Loss
Yahoo/AP
Wednesday, August 14, 2013 - 11:13am
tags:
Aveo Pharmaceuticals, earnings
Galena Biopharma: Best And Worst Case Scenario
Seeking Alpha
Wednesday, August 14, 2013 - 10:40am
tags:
Galena Biopharma, Abstral, breakthrough pain, breast cancer, NeuVax
Pfizer, Sanford-Burnham Team Up on Obesity, Diabetes Target Research
GenEngNews
Wednesday, August 14, 2013 - 10:23am
tags:
Pfizer, Sanford-Burnham Medical Research Institute, R&D, obesity, diabetes
Novartis to Review Business as Reinhardt Becomes Chairman, Would Consider a $10 Billion Purchase
Bloomberg
Wednesday, August 14, 2013 - 10:21am
tags:
Novartis, Joerg Reinhardt, M&A
Novartis, Pfizer Said to Be Out of Bidding for Onyx
Bloomberg
Wednesday, August 14, 2013 - 10:19am
tags:
Novartis, Pfizer, ONYX Pharmaceuticals, Amgen, M&A
Receptos Could Meet With A More Positive Reception
Seeking Alpha
Wednesday, August 14, 2013 - 10:16am
tags:
Receptos, Novartis, Gilenya, MS, multiple sclerosis, RPC1063
China to launch fresh pharmaceutical bribery probe
Yahoo/Reuters
Wednesday, August 14, 2013 - 9:32am
tags:
China, Novartis
MannKind's inhaled insulin Afrezza meets goals in 2 late-stage studies of diabetes patients
Yahoo/AP
Wednesday, August 14, 2013 - 9:17am
tags:
insulin, diabetes MannKind, Afrezza, inhaled insulin
Merck rolls out new training program for Zilmax customers
Reuters
Wednesday, August 14, 2013 - 9:16am
tags:
Merck, Zilmax, animal health
FDA Delivers a Double Dose of Good News in the Fight Against HIV
Motley Fool
Wednesday, August 14, 2013 - 9:15am
tags:
FDA, HIV, Alere, Alere Determine, Tivicay, vaccines, ViiV Healthcare, GSK, Shionogi, Pfizer
Cancer Breakthrough Could Mean Big Gains for This Pharma Giant
Yahoo/Street Authority
Wednesday, August 14, 2013 - 9:13am
tags:
lung cancer, Eli Lilly, necitumumab, non-small cell lung cancer
[video]Time to Panic About Pfizer's Upcoming Patent Expirations?
Motley Fool
Wednesday, August 14, 2013 - 9:11am
tags:
patents, Pfizer
2 Biotechs Aim To Capitalize On The Treatment Of Melanoma
Seeking Alpha
Tuesday, August 13, 2013 - 4:13pm
tags:
melanoma, Amgen, OncoSec, Vical, TVEC, NeoPulse
Osiris shares rocket, company details Grafix study
Yahoo/AP
Tuesday, August 13, 2013 - 4:09pm
tags:
Grafix, Osiris Therapeutics, diabetes, diabetic foot ulcers
Report: Novartis Bails on Onyx Bid
Barron's
Tuesday, August 13, 2013 - 4:06pm
tags:
Novartis, ONYX Pharmaceuticals, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.